Sat, Aug 30, 2014, 1:10 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Santarus, Inc. (SNTS) Message Board

  • nowwheretogo22004 nowwheretogo22004 Dec 29, 2010 8:06 AM Flag

    2011 will be a great year for SNTS

    This year the company was dealing with generic competition for Zegerid and a manufacturing recall for Glumetza (500 mg tablets only)and they went through a staff reduction to reduce their costs to the new expectations.

    Now we expect an announcement that manufacturing on those tablets have resumed. That should happen within a month. Cycloset was launched in November. We will start to get some indication on expected sales there. Rhucin is in the FDA approval cycle and should launch in the 2nd half of 2011, if all goes well. They will also submit an NDA for Budesonide in the 2nd half of 2011, as the European trials have gone well.

    The stock had rightfully been depressed this year due to the problems that were encountered. There is a lot of good news out there this year with multiple drugs already approved with other drugs moving quickly toward approval. I honestly believe we will see $6 a share this year as more of this development comes to fruition. That would only be a $360M market cap, so I believe that is a reasonable number, unless they suffer more setbacks. I just believe at this point, the bad news is behind them.

    Happy New Year to all the SNTS longs!

 
SNTS
31.960.00(0.00%)Dec 31 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.